Patents by Inventor Shyam KRISHNAN

Shyam KRISHNAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11871050
    Abstract: Some implementations include methods for replacing advertisements that have been inserted into a manifest associated with live streaming and may include receiving a request for a manifest from a player to enable a user to watch a live stream of an event. The request may be received at a first time when the live stream is already in progress. The manifest may be generated to include content fragments associated with the live event and advertisements based on first set of selection criteria. The manifest may be sent to the player to enable the user to watch the live stream. A seek back request may be received from the player to enable the user to watch the live stream at a second time earlier than the first time. The manifest may be updated to replace at least one advertisement with a replacement advertisement selected based on second set of selection criteria.
    Type: Grant
    Filed: August 17, 2021
    Date of Patent: January 9, 2024
    Assignee: Amazon Technologies, Inc.
    Inventors: Kyle Koceski, Shyam Krishnan Moni, Varun Chadha, Yongjun Wu, Abhishek Kumar
  • Publication number: 20230357347
    Abstract: This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt and/or hydrate and/or prodrug of the compound) that modulate (e.g., agonize or partially agonize or antagonize) glucagon-like peptide-1 receptor (“GLP-1R”) and/or the gastric inhibitory polypeptide receptor (“GIPR”). The chemical entities are useful, e.g., for treating a subject (e.g., a human) having a disease, disorder, or condition in which modulation (e.g., agonism, partial agonism or antagonism) of GLP-1R and/or GIPR activities is beneficial for the treatment or prevention of the underlying pathology and/or symptoms and/or progression of the disease, disorder, or condition. In some embodiments, the modulation results in an enhancement of (e.g., an increase in) existing levels (e.g., normal or below normal levels) of GLP-1R and/or GIPR activity (e.g., signaling). In some embodiments, the chemical entities described herein further modulate (e.g.
    Type: Application
    Filed: December 22, 2022
    Publication date: November 9, 2023
    Inventors: Johan Enquist, Shyam Krishnan, Suman Atwal, Daniel Erlanson, Raymond V. Fucini, Stig Hansen, Andrew Sawayama, Steven Sethofer
  • Publication number: 20230187808
    Abstract: An exemplary embodiment of the present disclosure provides a wireless network system comprising a mobile access point, a wireless device, and an actuator. The actuator further configured to move the mobile access point to a position having an improved line of sight condition between the wireless device and the mobile access point.
    Type: Application
    Filed: May 11, 2021
    Publication date: June 15, 2023
    Inventors: Yubing Jian, Raghupathy Sivakumar, Shyam Krishnan Venkateswaran, Ching-Lun Tai
  • Publication number: 20230151074
    Abstract: This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt) that modulate (e.g., agonize or partially agonize or antagonize) glucagon-like peptide-1 receptor (“GLP-1R”) and/or the gastric inhibitory polypeptide receptor (“GIPR”). The chemical entities are useful, e.g., for treating a disease, disorder, or condition in which modulation (e.g., agonism, partial agonism or antagonism) of GLP-1R and/or GIPR activities is beneficial for the treatment or prevention of the underlying pathology and/or symptoms and/or progression of the disease, disorder, or condition. In some embodiments, modulation results in enhancement of (e.g., increases) existing levels (e.g., normal or below normal levels) of GLP-1R and/or GIPR activity (e.g., signaling). In some embodiments, the chemical entities described herein further modulate (e.g., attenuate, uncouple) ?-arrestin signaling relative to what is observed with the native ligand.
    Type: Application
    Filed: May 13, 2022
    Publication date: May 18, 2023
    Inventors: Daniel Erlanson, Raymond V. Fucini, Stig Hansen, Jeff Iwig, Shyam Krishnan, Enrique Moya, Steven Sethofer
  • Patent number: 11535660
    Abstract: This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt and/or hydrate and/or prodrug of the compound) that modulate (e.g., agonize or partially agonize or antagonize) glucagon?like peptide?1 receptor (“GLP?1R”) and/or the gastric inhibitory polypeptide receptor (“GIPR”). The chemical entities are useful, e.g., for treating a subject (e.g., a human) having a disease, disorder, or condition in which modulation (e.g., agonism, partial agonism or antagonism) of GLP?1R and/or GIPR activities is beneficial for the treatment or prevention of the underlying pathology and/or symptoms and/or progression of the disease, disorder, or condition. In some embodiments, the modulation results in an enhancement of (e.g., an increase in) existing levels (e.g., normal or below normal levels) of GLP?1R and/or GIPR activity (e.g., signaling). In some embodiments, the chemical entities described herein further modulate (e.g.
    Type: Grant
    Filed: March 22, 2019
    Date of Patent: December 27, 2022
    Assignee: Cannot Therapeutics, Inc.
    Inventors: Johan Enquist, Shyam Krishnan, Suman Atwal, Daniel Erlanson, Raymond V. Fucini, Stig Hansen, Andrew Sawayama, Steven Sethofer
  • Patent number: 11442717
    Abstract: A network device includes a first agent programmed to provide a functionality of the network device. The network device also includes a message bus, distinct from the first agent, that identifies an update associated with the first agent, the update includes differential state information based, at least in part, on a state of the first agent, the state of the first agent is stored in a data structure exclusively managed by the first agent; in response to identifying the update: identifies a second agent that is subscribed to the first agent; and performs an action set to provide the second agent with access to the update.
    Type: Grant
    Filed: March 31, 2020
    Date of Patent: September 13, 2022
    Assignee: Arista Networks, Inc.
    Inventors: Roman Olegovich Chertov, Adam James Sweeney, Hugh W. Holbrook, Karthik Shyam Krishnan Subraveti
  • Patent number: 11356516
    Abstract: Methods and apparatus are described for facilitating the client-side caching of media content based on one or more properties of the media content. Information relating to the cacheability of different types of content is communicated to the media player on a client device in the manifest or playlist employed by the media player to request fragments of the media content. The media player uses this information to make decisions about how to cache the corresponding content.
    Type: Grant
    Filed: July 23, 2021
    Date of Patent: June 7, 2022
    Assignee: Amazon Technologies, Inc.
    Inventors: Yongjun Wu, Kyle Koceski, Kyle Alexander Woo, Vasanthakumar Soundararajan, Shiranchai Taneja, Shyam Krishnan Krishnan Moni, Jake O'Halloran
  • Publication number: 20210303288
    Abstract: A network device includes a first agent programmed to provide a functionality of the network device. The network device also includes a message bus, distinct from the first agent, that identifies an update associated with the first agent, the update includes differential state information based, at least in part, on a state of the first agent, the state of the first agent is stored in a data structure exclusively managed by the first agent; in response to identifying the update: identifies a second agent that is subscribed to the first agent; and performs an action set to provide the second agent with access to the update.
    Type: Application
    Filed: March 31, 2020
    Publication date: September 30, 2021
    Inventors: Roman Olegovich Chertov, Adam James Sweeney, Hugh W. Holbrook, Karthik Shyam Krishnan Subraveti
  • Patent number: 11070418
    Abstract: A network device includes a storage and a message bus. The storage stores subscription information. The message bus distributes state information associated with a first agent to at least two agents based on the subscription information. The message bus is distinct from the first agent. The state information is stored in a data structure exclusively managed by the first agent. The message bus, after distributing the state information, makes a determination that a connection to one of the at least two agents has been closed; and performs, based on the determination, an action set to prevent attempts to distribute future state information to the one of the at least two agents.
    Type: Grant
    Filed: March 31, 2020
    Date of Patent: July 20, 2021
    Assignee: Arista Networks, Inc.
    Inventors: Roman Olegovich Chertov, Adam James Sweeney, Hugh W. Holbrook, Karthik Shyam Krishnan Subraveti
  • Patent number: 9580427
    Abstract: Provided herein are compounds such as the compounds having the structure of Formula (XI) and methods of using the same, such as methods of inhibiting kinases.
    Type: Grant
    Filed: May 16, 2012
    Date of Patent: February 28, 2017
    Assignee: The Regents of the University of California
    Inventors: John William Taunton, Jr., Jesse McFarland, Shyam Krishnan, Jonathan Choy
  • Patent number: 9505766
    Abstract: Methods of inhibiting kinases using kinase inhibitors having olefin moieties are disclosed.
    Type: Grant
    Filed: August 18, 2014
    Date of Patent: November 29, 2016
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: John William Taunton, Jr., Rebecca Maglathlin, Iana Serafimova, Michael S. Cohen, Rand Miller, Ville Paavilainen, Jesse McFarland, Shyam Krishnan
  • Patent number: 9452974
    Abstract: Provided herein are compositions including diastereomers in substantially diastereomerically pure form and enantiomers in substantially enantiomerically pure form, and processes for preparing them and converting them to metyrosine.
    Type: Grant
    Filed: August 8, 2014
    Date of Patent: September 27, 2016
    Assignee: ATON PHARMA, INC.
    Inventors: Kevin John Halloran, Alex Comely, Zhengming Chen, Shyam Krishnan
  • Publication number: 20150045343
    Abstract: Methods of inhibiting kinases using kinase inhibitors having olefin moieties are disclosed.
    Type: Application
    Filed: August 18, 2014
    Publication date: February 12, 2015
    Inventors: John William Taunton, Jr., Rebecca Maglathlin, Iana Serafimova, Michael S. Cohen, Rand Miller, Ville Paavilainen, Jesse McFarland, Shyam Krishnan
  • Publication number: 20140350284
    Abstract: Provided herein are compositions including diastereomers in substantially diastereomerically pure form and enantiomers in substantially enantiomerically pure form, and processes for preparing them and converting them to metyrosine.
    Type: Application
    Filed: August 8, 2014
    Publication date: November 27, 2014
    Inventors: Kevin John HALLORAN, Alex COMELY, Zhengming CHEN, Shyam KRISHNAN
  • Publication number: 20140323464
    Abstract: Provided herein are kinase inhibiting compounds and methods of using the same.
    Type: Application
    Filed: May 16, 2012
    Publication date: October 30, 2014
    Inventors: John William Taunton, JR., Kenneth Albert Brameld, David Michael Goldstein, Jesse Mcfarland, Shyam Krishnan, Jonathan Choy
  • Patent number: 8841486
    Abstract: Provided herein are compositions including diastereomers in substantially diastereomerically pure form and enantiomers in substantially enantiomerically pure form, and processes for preparing them and converting them to metyrosine.
    Type: Grant
    Filed: October 29, 2010
    Date of Patent: September 23, 2014
    Assignee: Aton Pharma
    Inventors: Kevin John Halloran, Alex Comely, Zhengming Chen, Shyam Krishnan
  • Publication number: 20130035325
    Abstract: Methods of inhibiting kinases using kinase inhibitors having olefin moieties are disclosed.
    Type: Application
    Filed: November 16, 2010
    Publication date: February 7, 2013
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: John William Taunton, JR., Rebecca Maglathlin, Iana Serafimova, Michael S. Cohen, Rand Miller, Ville Paavilainen, Jesse McFarland, Shyam Krishnan
  • Publication number: 20110104765
    Abstract: Provided herein are compositions including diastereomers in substantially diastereomerically pure form and enantiomers in substantially enantiomerically pure form, and processes for preparing them and converting them to metyrosine.
    Type: Application
    Filed: October 29, 2010
    Publication date: May 5, 2011
    Inventors: Kevin John HALLORAN, Alex COMELY, Zhengming CHEN, Shyam KRISHNAN
  • Patent number: 7773003
    Abstract: A method for decoding an input bit stream encoded using Huffman encoding generates a lookup table using a standard Huffman code book. Thereafter, at least three bits are extracted from the input bit stream. The at least three bits extracted are used to traverse the lookup table. Subsequently, a data set corresponding to a Huffman code word is accessed, thereby decoding the input bit stream.
    Type: Grant
    Filed: March 5, 2009
    Date of Patent: August 10, 2010
    Assignee: Freescale Semiconductor, Inc.
    Inventors: Srinidhi Thirumalae Narayana, Shyam Krishnan Moni